title: Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman.
abstract: Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma is a rare and provisional entity, characterised by cutaneous involvement and aggressive clinical behaviour. The case is here presented of a young woman with concurrent cutaneous and systemic involvement. Despite multi-agent chemotherapy, only partial remission could be achieved, and the patient died from therapy-resistant respiratory and circulatory failure. This case report is intended to add to the data collected on this rare entity, with only about 20 cases as yet described.
authors.affiliation: 1st Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
authors.forename: J
authors.initials: J
authors.lastname: Csomor
authors.forename: A
authors.initials: A
authors.lastname: Bognár
authors.forename: S
authors.initials: S
authors.lastname: Benedek
authors.forename: J
authors.initials: J
authors.lastname: Sinkó
authors.forename: S
authors.initials: S
authors.lastname: Fekete
authors.forename: L
authors.initials: L
authors.lastname: Krenács
authors.forename: A
authors.initials: A
authors.lastname: Matolcsy
authors.forename: L
authors.initials: L
authors.lastname: Reiniger
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D015334:Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; D006801:Humans; D016130:Immunophenotyping; D007621:Karyotyping; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D014178:Translocation, Genetic; D017211:Treatment Failure; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide